Vale, Baby Boy .

HRN: 23-76-24  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/03/2023
CEFOTAXIME 500MG (VIAL)
10/03/2023
10/12/2023
IV
200mg
BID
Neonatal Pneumonia
Waiting Final Action 
10/03/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
10/03/2023
10/09/2023
IV
30mg
BID
Neonatal Pneumona
Waiting Final Action 
10/11/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
10/11/2023
10/18/2023
IV
275mg
Q8
PSNB
Waiting Final Action 
10/24/2023
MUPIROCIN 2%, 15G (TUBE)
10/24/2023
10/31/2023
TOPICAL
2%
BID
Soft Tissue Injury
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: